Mrna Covid Vaccines

This year's Nobel Prize in Medicine has been awarded to scientists for discoveries that enabled the development of mRNA vaccines against COVID-19.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...

Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.

The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.

Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.

A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.

Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.

Six African countries have been chosen to establish their own mRNA vaccine production, the World Health Organization said Friday, with the continent largely shut out of access to Covid jabs.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

India's first homegrown mRNA COVID-19 vaccine is currently under final clinical trial stages, the government said on Thursday.

A US government-appointed panel of medical experts on Thursday unanimously recommended mRNA Covid vaccines made by Pfizer and Moderna over Johnson & Johnson's shot, in light of its weaker protection and greater risks.

The European Medicines Agency said Wednesday that Johnson & Johnson's Covid vaccine can be used as a booster shot two months after the first dose was administered, or after receiving other mRNA shots.

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.

This year's Nobel Prize in Medicine has been awarded to scientists for discoveries that enabled the development of mRNA vaccines against COVID-19.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...

Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.

The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.

Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.

A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.

Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.

Six African countries have been chosen to establish their own mRNA vaccine production, the World Health Organization said Friday, with the continent largely shut out of access to Covid jabs.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

India's first homegrown mRNA COVID-19 vaccine is currently under final clinical trial stages, the government said on Thursday.

A US government-appointed panel of medical experts on Thursday unanimously recommended mRNA Covid vaccines made by Pfizer and Moderna over Johnson & Johnson's shot, in light of its weaker protection and greater risks.

The European Medicines Agency said Wednesday that Johnson & Johnson's Covid vaccine can be used as a booster shot two months after the first dose was administered, or after receiving other mRNA shots.

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.